Meridian Bioscience, Inc. (VIVO)

NASDAQ: VIVO · IEX Real-Time Price · USD
33.55
+2.20 (7.02%)
At close: Jul 6, 2022 4:00 PM
33.88
+0.33 (0.98%)
After-hours: Jul 6, 2022 6:57 PM EDT

Stock Price Forecast

According to 8 stock analysts, the average 12-month stock price forecast for VIVO stock is $30.6, which predicts a decrease of -8.79%. The lowest target is $30.3 and the highest is $31.5. On average, analysts rate VIVO stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $30.3 $30.6 $30.6 $31.5
Change -9.69% -8.79% -8.79% -6.11%

Analyst Ratings

The average analyst rating for VIVO stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '22Feb '22Mar '22Apr '22May '22Jun '22
Strong Buy 433333
Buy 444444
Hold 111111
Sell 000000
Strong Sell 000000
Total 988888

Financial Forecast

Revenue This Year
347.89M
Increased by 9.44%
Revenue Next Year
330.43M
Decreased by -5.02%
EPS This Year
1.42
Decreased by -13.76%
EPS Next Year
1.08
Decreased by -24.01%
Year 201720182019202020212022202320242025
Revenue
200.77M213.57M201.01M253.67M317.90M347.89M330.43M332.01M340.26M
Revenue Growth
2.39%
6.38%
-5.88%
26.19%
25.32%
9.44%
-5.02%
0.48%
2.49%
EPS
0.510.560.571.081.651.421.080.850.69
EPS Growth
-33.77%
9.80%
1.79%
89.47%
52.78%
-13.76%
-24.01%
-20.93%
-19.35%
No. Analysts -----4422

Revenue Forecast

Revenue 2022202320242025
High 361.8M 340.7M 348.6M 353.9M
Avg 347.9M 330.4M 332.0M 340.3M
Low 330.8M 316.9M 322.0M 330.1M

Revenue Growth

Revenue Growth 2022202320242025
High
14.4%
-2.1%
5.5%
6.6%
Avg
10.0%
-5.0%
0.5%
2.5%
Low
4.6%
-8.9%
-2.5%
-0.6%

EPS Forecast

EPS 2022202320242025
High 1.51 1.25 0.90 0.72
Avg 1.42 1.08 0.85 0.69
Low 1.32 0.91 0.83 0.67

EPS Growth

EPS Growth 2022202320242025
High
-9.3%
-12.2%
-17.0%
-16.1%
Avg
-14.7%
-24.0%
-20.9%
-19.3%
Low
-20.7%
-35.9%
-23.3%
-21.8%